Metabolic Score for Insulin Resistance (METS-IR) Predicts Adverse Cardiovascular Events in Patients with Type 2 Diabetes and Ischemic Cardiomyopathy
Xuehe Zhang,Fen Liu,Wenling Li,Jixin Zhang,Tong Zhang,Xiaolin Yu,Junyi Luo,Qian Zhao,Jinyu Zhang,Binbin Fang,Yining Yang,Xiaomei Li
DOI: https://doi.org/10.2147/DMSO.S404878
2023-05-06
Abstract:Xuehe Zhang, 1 Fen Liu, 1 Wenling Li, 1 Jixin Zhang, 1 Tong Zhang, 1 Xiaolin Yu, 2 Junyi Luo, 1 Qian Zhao, 1 Jinyu Zhang, 1 Binbin Fang, 1 Yining Yang, 2 Xiaomei Li 1 1 Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China; 2 Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, People's Republic of China Correspondence: Yining Yang, Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, 91 Tianchi Road, Urumqi, 830054, People's Republic of China, Tel +86-991-4361690, Email Xiaomei Li, Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, 137 Liyushan South Road, Urumqi, 830054, People's Republic of China, Tel +86-991-4362611, Email Purpose: This study aimed to evaluate the association between metabolic score for insulin resistance (METS-IR) and adverse cardiovascular events in patients with ischemic cardiomyopathy (ICM) and type 2 diabetes mellitus (T2DM). Methods: METS-IR was calculated using the following formula: ln[(2 × fasting plasma glucose (mg/dL) + fasting triglyceride (mg/dL)] × body mass index (kg/m 2 )/(ln[high-density lipoprotein cholesterol (mg/dL)]). Major adverse cardiovascular events (MACEs) were defined as the composite outcome of nonfatal myocardial infarction, cardiac death, and rehospitalization for heart failure. Cox proportional hazards regression analysis was used to evaluate the association between METS-IR and adverse outcomes. The predictive value of METS-IR was evaluated by the area under the curve (AUC), continuous net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Results: The incidence of MACEs increased with METS-IR tertiles at a 3‐year follow‐up. Kaplan‒Meier curves showed a significant difference in event-free survival probability between METS-IR tertiles (P< 0.05). Multivariate Cox hazard regression analysis adjusting for multiple confounding factors showed that when comparing the highest and lowest METS-IR tertiles, the hazard ratio was 1.886 (95% CI:1.613– 2.204; P< 0.001). Adding METS-IR to the established risk model had an incremental effect on the predicted value of MACEs (AUC=0.637, 95% CI:0.605– 0.670, P< 0.001; NRI=0.191, P< 0.001; IDI=0.028, P< 0.001). Conclusion: METS-IR, a simple score of insulin resistance, predicts the occurrence of MACEs in patients with ICM and T2DM, independent of known cardiovascular risk factors. These results suggest that METS-IR may be a useful marker for risk stratification and prognosis in patients with ICM and T2DM. Keywords: metabolic score for insulin resistance, ischemic cardiomyopathy, type 2 diabetes mellitus, major adverse cardiac events, prognosis Ischemic cardiomyopathy (ICM) refers to left ventricular systolic dysfunction caused by obstructive coronary artery disease (CAD) and is the most common cause of heart failure (HF) with reduced ejection fraction. 1 The main pathophysiological features of ischemic cardiomyopathy are left ventricular enlargement, decreased myocardial systolic and diastolic function, and further development of congestive heart failure. Type 2 diabetes mellitus (T2DM) and HF often coexist, and 15–25% of people with heart failure have diabetes. 2 The presence of diabetes is associated with reduced survival and increased hospitalization in patients with HF. 3 The pathophysiological mechanisms of heart failure in patients with T2DM are complex. In addition to general heart failure risk factors such as advanced age, ethnicity, genetic predisposition, hypertension, and smoking, 4 T2DM also increases the risk of ischemic heart failure by increasing the risk of CAD and directly affecting the myocardium, leading to structural and functional changes. 5 However, the clustering of these classical cardiovascular risk factors is insufficient to explain the excess coronary artery disease risk in patients with diabetes. This suggests that other factors may be involved. The main pathophysiological abnormalities of type 2 diabetes are insulin resistance (IR) and impaired insulin secretion. IR refers to the state in which insulin secretion is normal, but the sensitivity of tissues, organs and cells to insulin is reduced, and the role of insulin in promoting glucose uptake and utilization in target organs is reduced. 6 Insulin resistance plays an important role in the development of early vascular diseases in patients with diabetes. T2DM patients experience a long period of insulin resistance before the clinical onset of the d -Abstract Truncated-
endocrinology & metabolism